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Lycium barbarum polysaccharides (LBPs) are the major polysaccharides
extracted from L. barbarum, which is used in traditional Chinese
medicine (TCM) for treating diseases. Studies have shown that
LBPs have important biological activities, such as antioxidation,
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anti-aging, neuroprotection, immune regulation. LBPs inhibit oxidative
stress, improve neurodegeneration and stroke-induced neural injury,
increase proliferation and differentiation of neural stem cell, and
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promote neural regeneration. Here we have reviewed latest advances
in the biomedical activities of LBPs and improved methods for the
isolation, extraction, and purification of LBPs. Then, new discoveries
to decrease oxidative stress and cellular apoptosis, inhibit aging
progress, and improve neural repair in neurodegeneration and
ischemic brain injury have been discussed in detail through in vitro
cell culture and in vivo animal studies. Importantly, the molecular
mechanisms of LBPs in playing neuroprotective roles are further
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explored. Lastly, we discuss the perspective of LBPs as biomedical
compounds in TCM and modern medicine and provide the
experimental and theoretical evidence to use LBPs for the treatment
of aging-related neurological diseases and stroke-induced neural
injuries.

1

Introduction

Lycium barbarum polysaccharides (LBPs) are the
main biologically active components of L. barbarum,
which belongs to the Solanaceae family. The

commonly found L. barbarum is used in food
and traditional Chinese medicine (TCM) and
mainly includes Ningxia L. barbarum, Chinese
L. barbarum, and L. ruthenicum Murr. L. barbarum
wolfberry is used in TCM for nourishing the
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liver, kidney, lung, and brain to improve blood
circulation and organ function, etc. Wolfberry is
used as functional food in China [1, 2]. Wolfberry
contains more than 200 components, including
total saponins, phenylpropanes, flavonoids,
polyphenols, and polysaccharides. Studies have
shown that polysaccharides, vitamins, betaine,
and mixed extracts of wolfberry have biomedical
effects in anti-aging, improving vision, increasing
immunomodulation, and other biomedical
functions [3].
L. barbarum polysaccharides (LBPs) are the
main chemical components of wolfberry extract
and account for 5%–8% of wolfberry dry weight.
LBPs are mainly composed of glucose, arabinose,
rhamnose, mannose, xylose, and galactose. Studies
on the chemical structures and biological functions
of LBPs revealed that LBPs have various biological
functions, including antioxidation, anti-aging,
neuroprotection, and immunomodulation [3, 4].
To fully understand the medicinal application
and functional mechanisms of LBPs, we first
summarize the extraction methods used for LBPs
and then analyze the neuroprotective functions
of LBPs. We have also explored mechanisms
of neuroprotection mediated by LBPs for
developing the LBP-related products to improve
neurodegeneration and neural damage in
neurological diseases.

2

Isolation, extraction, and identification of
LBPs

2.1 Techniques for the isolation and extraction
of LBPs
Several methods are used for the isolation
of LBPs, which include hot water extraction,
enzyme-assisted extraction, microwave-assisted
extraction, and ultrasound-assisted extraction. The
pretreatment method of L. barbarum raw materials
involves drying and crushing raw materials into

small particles of different sizes. In recent years,
the development of new isolation methods has
overcome the shortcomings of traditional extraction
methods [5]. To select a suitable extraction
method, high extraction rates and the maintenance
of high biological activity of LBPs are mainly
considered. These methods are briefly discussed
here.
Hot water extraction is a traditional method
for the isolation of polysaccharide compounds,
but the long-term and high temperature used in
this method may degrade polysaccharides and
affect their biological activity. The productivity
of LBPs using this extraction method ranges
from 1.14% to 18.56% [2].
Enzyme-assisted extraction involves the use
of alkaline proteases to hydrolyze L. barbarum and
centrifuge the digested supernatant to purify
LBPs. The commonly include papain, cellulase,
and pectinase. When LBPs are extracted by the
enzymatic method, factors, such as the type
and dosage of enzymes, ratio of raw material to
liquid, time, pH, and temperature of enzymatic
hydrolysis, which affect their productivity, should
be considered. The product yield of LBPs extracted
by enzymatic method varies between 2.9498%
and 23.68% [6]. This method has the advantages
of high efficiency, easy operation, low cost, and
energy saving; however, the selection of enzyme
is specific, and factors, such as enzyme concentration, temperature, time, and pH, also affect
the biological functions of extracted LBPs.
Microwave-assisted extraction is a physical
approach that uses the crushing effect of
electromagnetic waves to extract LBPs. Advantages
include short extraction time, high production
rate, and lower cost. The raw material to liquid
ratio, temperature, time, and microwave power
used in this method have a great influence on
the extraction rate. The temperature used for
microwave extraction is usually between 50 and
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100 °C and the extraction time varies in different
studies. The most commonly used temperature
is approximately 1 h which can avoid the
decomposition and destruction of thermally
unstable substances caused by long-term high
temperature. Under the above conditions, the
yield of LBPs is between 6.6% and 19.1%, which
is a significant improvement when compared
with traditional hot water extraction [7].
Ultrasonic-assisted extraction utilizes the
thermal and mechanical effects of ultrasonic waves
to instantly extract L. barbarum. This method can
significantly improve the extraction efficiency of
polysaccharides. However, ultrasonic treatment
may affect the structure and molecular weight of
polysaccharides, thereby affecting their biological
activity. The extraction temperature used for
ultrasonic-assisted extraction is 60–90 °C, and the
ratio of raw material to liquid during extraction
is between 1:20 and 1:30. Due to the assistance
of ultrasound, the extraction time is between
15 and 50 min, significantly shorter than that
of other extraction methods. Most studies have
reported the use of ultrasonic power between
60 and 250 W. Under the above conditions, the
yield of LBPs is between 4.28% and 14.48% [8, 9].
The major advantages of ultrasonic microwave
extraction include fast extraction speed, low
energy consumption, and short time. This method
has been widely used in the extraction of active
ingredients of natural products [8, 10].
2.2 Purification and identification
Many studies evaluating the chemical composition
and structure of LBPs have revealed that LBPs
are mainly composed of polysaccharides, with
some polypeptides and proteins. The molecular
weight of LBPs is 10–2300 kDa. Approaches
for purifying LBPs from L. barbarum include
DEAE ion exchange cellulose, gel permeation
chromatography, and high-performance liquid

http://bsa.tsinghuajournals.com

chromatography (HPLC). It was shown that
glycoconjugates are composed of monosaccharides
and amino acid residues are the main structure
of LBPs by analyzing glycosidic bond of the
glycan backbone. More than 30 types of LBPs
have been purified and identified, which mainly
consist of arabinose, glucose, galactose, mannose,
xylose, rhamnose, and other monosaccharides.
Its monosaccharide is mainly composed of
rhamnosyl, arabinosyl, xylose, mannosyl, glucosyl,
and galactosyl. Their molar ratio in LBPs is
2.07:2.38:3.11:1.00:1.12:2.86. However, other
factors, such as the regions of origin of L.
barbarum, may affect the formation of the sugar
ring, type of glycosidic bonds, monosaccharide
composition, and the amount of individual
components [11].
Some studies have indicated that crude LBPs
can be purified using the DEAE-52 cellulose
(OH-) column and Sephadex G-50 column
chromatography to isolate LBP1 and LBP2 [12, 13].
Analysis using ultraviolet spectrum scanning and
column chromatography revealed that both LBP1
and LBP2 have a relatively uniform molecular
mass. Infrared spectroscopy showed that both
LBP1 and LBP2 are mainly composed of pyranose.
The relative molecular masses of LBP1 and LBP2
detected by HPLC were 367 and 358, respectively.
Gas chromatographic analysis determined that
the molar ratio of monosaccharide components of
LBP1 is galactose:mannose:glucose = 1.79:1.00:3.08
and that for LBP2 is galactose:mannose:glucose =
1.32:1.00:7.38 [2].

3

Antioxidative damage function and
molecular mechanism of LBP action

Several studies have given evidence on the
potential antioxidant activities of LBPs in many
tissues and cells. LBPs can significantly increase
levels of SOD and GSH-Px in the serum of mice
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and significantly reduce oxidative damage MDA
after skin fibroblasts cultured from newborn
Kunming mice were treated with LBPs. In this
study [14], LBPs were divided into high, medium,
and low dose groups and the control group.
Cell proliferation was examined using the
tetramethylazazole blue method (MTT assay).
LBPs were shown to promote the growth of
fibroblast cells and delay cell apoptosis to increase
cell survival. LBPs significantly increased the
activity of antioxidant enzymes in exercise-trained
mice and reduced lipid peroxidation in a rabbit
model of atherosclerosis. The exercising ability
of aging mice was found to be significantly
reduced compared with young mice; however,
after the aging mice drank water containing
LBPs, the continuous running time of mice was
prolonged, indicating that the exercise ability of
mice had increased. It also showed that LBPs
could enhance the animal's antifatigue ability.
After 24 h of treatment with LBPs, LBPs were
found to protect CoCl2-induced apoptosis of
retinal ganglion cells in mice, and inhibited the
production of reactive oxygen species (ROS) by
improving mitochondrial function. ROS include
oxygen free radicals, hydroxyl radicals, superoxide
anion, hydrogen peroxide, and nitric oxide. In
the CoCl2-induced oxidative stress model of rat
retinal ganglion cells (RGCs), LBPs were found
to exert an antioxidative damage effect. After
pretreatment of RGCs with LBPs for 24 h, LBPs
were found to effectively reduce the occurrence
of CoCl2-induced hypoxia in the RGC model,
reduce cell apoptosis of RGCs, inhibit oxidative
stress response, and improve the potential
function of mitochondria to produce antioxidant
protection on RGC cells [15].
Studies have also shown that the antioxidant
activity of LBPs has a protective effect on
oxidative damage of the skin, can delay cell
entry into senescence and apoptosis, indicating
the antioxidative damage function of LBPs [16].

LBPs can also enhance the phagocytic ability of
macrophages by increasing the production of
NO and acid phosphatase in macrophages, and
thus, produce significant antioxidant activity.
LBPs can significantly inhibit the damage
mediated by oxidative toxic substances to neural
cells and regulate oxidative stress by inhibiting
the caspase-3 activation and ROS production. On
stressed retinal pigmental epithelium (RPE), LBPs
can reduce ROS production to prevent ROSinduced apoptosis by scavenging free radicals
and regulating the expression of downstream
genes. After the rats were fed LBPs, the activity of
the antioxidant enzymes manganese superoxide
dismutase (MnSOD) and glutathione peroxidase
and GSH expression significantly increased [17].
LBPs can regulate ROS activation and the
expression of transcription factors, such as Nrf2
and NF-κB. LBPs can also affect the transcription
and expression of various genes in the body
and participate in the regulation of important
biological processes, such as inflammation,
development, immunity, cell growth, and stem
cell regeneration. SOD plays an important role in
maintaining the dynamic balance of ROS. Studies
have shown that the exogenous supplementation
of LBPs significantly increased SOD activity in
the retina after 3 months [18, 19].
A recent study indicated that pretreatment of
the human retinal epithelial cell line (ARPE-19)
with LBPs showed that LBPs are highly efficient
in reducing oxidative damage and inhibiting
cell apoptosis. Furthermore, LBPs may regulate
the expression of proteins involved in the
apoptotic pathway and activate the Nrf2 signaling
pathway [20].
Many studies have shown that the antioxidant
and antiaging functions of LBPs are performed
mainly through three pathways mediated by the
NF-κB pathway (the intracellular mitochondrial
pathway), endoplasmic reticulum pathway, and
extracellular receptor pathway to protect cells
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from oxidative stress and apoptosis. NF-κB is
an important transcriptional regulator in cells. In
addition to participating in antioxidative stress,
it also regulates the expression of apoptosisrelated genes. NF-κB plays functions in the
mitochondrial pathway through the transcriptional
regulation of X-linked inhibitor of apoptosis
protein (XIAP), c-IAP-1, and c-IAP-2, members
of the inhibitor of apoptosis protein (IAP) family.
XIAP is a key factor for NF-κB to inhibit apoptosis.
XIAP can specifically inhibit the activation of the
apoptotic effector caspase (GSH), thereby blocking
the release of cytochrome c (cyt c) in cells, and
subsequently, inhibiting cell apoptosis [21]. In
the endoplasmic reticulum signaling pathway,
the transcription factor NF-κB plays a role through
the endoplasmic reticulum stress-mediated Jun
N-terminal kinase (JNK) signaling pathway. After
the cell is stimulated by calcium homeostasis
disorder and oxidative stress, the accumulation
of unfolded or misfolded proteins in the
endoplasmic reticulum eventually leads to
apoptosis. Endoplasmic reticulum stress initiates
cell apoptosis mainly through protein transcription
activation, protease activation, and c-JNK signal
activation. Studies have shown that NF-κB
activation can inhibit cell apoptosis caused by
the Fas/FasL signaling pathway. Treating cells
with monoethylhexyl phthalate can cause cell
apoptosis through NF-κB activation. After
knocking out genes related to the death region,
the number of NF-κB accumulating in the FasL
promoter region is reduced, causing Fas/FasL
Increased gene expression promotes cell
apoptosis. LBPs inhibit the NF-κB signaling
pathway, thereby activating cell function and
antiaging [22, 23].

4

Neuroprotective effect and mechanism of
LBPs

L. barbarum has been used in several decoctions
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of TCM for the treatment of neural injury and
neurological diseases for a long time. In recent
years, a large number of studies have shown
that LBPs have neuroprotective effects on neurodegenerative diseases, cerebral ischemia, brain
injury, and other neurological diseases.
4.1 Mechanism of neuroprotection in neurodegenerative diseases
Neurodegenerative diseases are mainly caused
by the degeneration and apoptosis of neurons
in the brain. Alzheimer’s disease (AD) is the
most common neurodegenerative disease; its
characteristic pathology involves the deposition
of beta amyloid (Aβ) to form Aβ plaques, which
are mainly formed in the cerebral cortex and
hippocampus. Studies have shown that LBPs
can reduce the formation of Aβ plaques, and
thus, protect neural cells from degeneration.
Moreover, the mechanism of preventing Aβ
deposits depends on the solvents used to extract
LBP. The LBPs extracted by hot water mainly
inhibit the apoptosis-related XIAP pathway and
reduce the production of Aβ deposits. The LBPs
extracted from alkaline solutions mainly activate
the Akt pathway to have neuroprotective effects
and promote neural cell survival. Some studies
also showed that LBPs can improve the effect
on memory impairment in AD at cellular and
molecular levels [24].
Parkinson’s disease (PD) is the second largest
neurodegenerative disease after AD. PD is mainly
caused by environmental factors and genetic
mutations that produce protein aggregates
of Lewy body with α-synuclein as the main
component, causing moderate apoptosis and
necrosis of dopamine neurons in the substantia
nigra. Studies have reported that LBPs can
significantly improve MPTP (1-methyl-4-phenyl1,2,3,6-tetrahydropyridine)-induced dyskinesia
in a mouse model with PD. Using fluorescence
quantitative real time PCR (qRT-PCR) and western
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blot analysis, LBPs were found to significantly
increase the gene expression of SOD2, CAT, and
GPX1 in dopamine neurons in the midbrain of PD
mice and inhibited MPTP-induced α-synuclein
deposition. At the same time, LBPs are found
to mainly strengthen the phosphorylation of
Akt and mTOR signaling molecules and play a
neuroprotective effect by activating the PTEN/
AKT/mTOR signaling pathway, suggesting that
LBPs can be used compatibly with TCM for
treating PD and other neurodegenerative
diseases [25]. Other studies have found that both
low- and high-dose LBP can inhibit the apoptosis
of dopamine neurons in the mouse and rat PD
model induced by MPTP, reduce motor defects
in PD mice and rats, and improve some aspects
of memory deficits in PD mice. Further studies
showed that the expression of PTEN, p-Akt, and
p-mTOR proteins significantly increased in the
MPTP-induced mouse PD model. After LBP
treatment, the expression of these proteins was
effectively reduced, indicating that LBPs act
mainly by regulating the PTEN/AKT/mTOR
signaling pathway to exert neuroprotective effects
[26]. The mechanisms by which LBP inhibits the
PTEN/AKT/mTOR signaling pathway are shown
in Fig. 1.
Elderly visual impairment and blindness are
mainly caused by the aging and degeneration
of the retina and optic nerves. Treatment with
LBPs can significantly reduce these injuries by
enhancing the autophagic ability of endogenous
microglia in the body. Ultrastructural alterations
of the optic nerves in retinal degenerative diseases
are the most common pathological changes that
reflect the degeneration and apoptosis of optic
nerve cells. Optic nerve degeneration reduced
axon formation in RGCs and the injured axons
then triggers RGC death. After LBPs were
administered to rats with optic nerve degeneration
for 3 months, the density of the optic nerve was
found to increase, the number of microfilaments

Fig. 1 The neuroprotective mechanisms of Lycium barbarum
polysaccharides (LBPs) through the PTEN/AKT/mTOR signaling
pathway [25, 26]. A. LBPs inhibit the PTEN/AKT/mTOR signaling
pathway activated by oxidative stress. B. LBP reduces cell
autophagy. C. LBPs inhibit cell apoptosis.

and microtubules in axons also increased, and
axonal demyelination improved. After treatment
with LBPs, the morphology of the myelin sheath
almost returned to normal, even though a small
part of the axons remained demyelinated [27].
The increase in intraocular pressure caused by
senile glaucoma gradually damages the optic
nerve and causes loss of vision. In the acute
ocular hypertension model of rats, LBPs were
administered before and after the model was
established. Both the thickness of the retina and
electrophysiological function of the optic nerve
improved significantly, indicating that LBPs can
promote the regeneration of retinal neural stem
cells and prevent the degeneration of the optic
nerve and retina. The optic nerve transection
model is often used to study RGC degeneration.
In this model, obvious pathological alterations
of the microglia and macrophages can be found
and autophagy of the optic nerve can also be
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observed. Studies have shown that LBPs can
increase the survival of RGCs, promote the polar
response of the microglia and macrophages, and
delay the degenerative changes of RGCs, thereby
improving optic nerve degeneration. Thus LBPs
have both preventive and therapeutic effects on
optic nerve injuries caused by retinal diseases,
such as glaucoma [28, 29].
4.2 Mechanism of neuroprotection in ischemic
brain injury
Cerebrovascular diseases mainly affect the elderly.
Ischemic stroke accounts for the most cases of
cerebrovascular diseases. An effective treatment
for ischemic stroke involves selectively blocking
the excitotoxic effects of neuronal cells and
maintain the normal physiological functions of
glutamate neurons. Three N-methyl-D-aspartate
receptors (NMDAR) subunits—NR1, NR2 (A–D),
NR3 (A, B)—are located on glutamate neurons.
The functional NMDAR is a tetrameric structure
composed of two NR1 subunits with two NR2
and/or NR3 subunits [30]. NR2 subunit isomers
(NR1/NR2A, NR1/NR2B) exhibit different
physiological and pharmacological functions.
From a functional analysis, the NR2A subunit
produces stronger neuroprotection by activating
the CREB or Akt signaling pathway [31].
Activating NR2A can induce the phosphorylation
of CREB and induce overexpression of brainderived neurotrophic factor (BDNF), thereby
enhancing the survival of neuronal cells. Studies
have shown that certain drugs can produce
neuroprotective effects by enhancing CREB
activity. By contrast, activation of the NR2B
receptor outside the synapses can initiate apoptosis
in neural cells by promoting ROS production
and inhibiting CREB expression [32]. The
mechanism by which certain drugs can produce
neuroprotection through NR2A or NR2B subunits
is unclear.
Studies have shown that the neuroprotective
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effect of LBPs on ischemic brain injury is mainly
through the activation of the NR2A subunit and
inhibition of signal transduction of the NR2B
subunit. In a rat model of cerebral ischemic injury,
LBPs can improve the memory impairment
caused by cerebral ischemia and increase the
tolerance of cerebral cortex neurons to hypoxia
injury. Further analysis indicated that LBPs
enhance the expression of major related proteins
in the NR2B and NR2A signaling pathways, such
as NR2B, nNOS, Bcl-2-associated death promoter
(BAD), cyt c, and cleaved caspase-3. Moreover,
LBPs can reduce hypoxia-induced ROS response,
cell calcium influx, and mitochondrial permeability.
LBPs were shown to produce neuroprotection
for ischemic brain injury by increasing NR2A
expression and inhibiting the bidirectional effect
of the NR2B signaling pathway. In addition,
LBPs can improve memory loss and motor
dysfunction of neurological disorders caused by
focal cerebral ischemia. Thus, LBPs can be used
as a preventive and therapeutic drug for ischemic
stroke [33].
Recent studies reported that the mechanism
of LBP producing neuroprotection is mediated
through in vitro and in vivo studies [34]. To
evaluate whether LBPs induce neuroprotection
through the NR2A-Akt-CREB signaling pathway,
one study showed that the expression of NR2A
remained at a normal level within 2 h of exposure
to hypoxic glucose depletion (OGD) [35]; however,
after 4 and 8 h of OGD exposure, the expression
of NR2A decreased to 66.5% and 33.5% of the
normal level, respectively. The expression of
Akt protein was decreased to 59.5% after 30 min
of OGD treatment. The expression of CREB
protein remained unchanged after 1 h of OGD
treatment, but decreased to 50.8%, 46.2%, and
32.1% after 2, 4, and 8 h of OGD treatment,
respectively. Further analysis of the effect of
LBPs on the expression of the main proteins in
the NR2A signaling pathway showed that even
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though the expression of NR2A, Akt, and CREB
did not change after 1 h of OGD treatment, after
4 h, LBP significantly improved the expression
of NR2A, Akt, and CREB. This study indicated
that LBPs protected the CA1 neurons from OGD
damage, and reduced apoptosis in injured neural
cells in the cerebral cortex, thereby producing
neuroprotective effects. Other studies have shown
that the neuroprotection induced by LBPs is
mainly through the inhibition of related proteins
in the NR2B signaling pathway, including NR2B,
BAD, and cyt c and by the removal of caspase-3,
mitochondrial stress, and Ca2+ influx [34]. Recent
studies have also reported that LBPs can increase
the expression of Nrf2 and inhibit the expression
of HO-1 through the Nrf2/HO-1 signaling
pathway to inhibit Nrf2-induced cell apoptosis,
thereby reducing oxidative damage and protecting
cell function [20, 33]. The mechanism by which
LBPs neuroprotect against ischemic nerve injury
is shown in Fig. 2.

Fig. 2

LBPs inhibit the NR2B signaling pathway and activate the

NR2A signaling pathway to induce neuroprotection against stroke
and hemorrhage-induced hypoxia injury [33].

4.3 LBPs promote neural regeneration and
prevent aging
Recent studies have shown that neural stem cells
located in the brain and spinal cord play a key
role in delaying aging and neurodegeneration.
With increasing age, a gradual decrease of
neurons occurs in the brain, which is the main
cause for neurodegeneration and aging. Latest
studies have reported that Cxcl13 increases the
functions of the aging brain significantly through
the CXCR5/5/CXCL13 signaling pathway, whereas
the gradual decrease of Cxcr5 leads to a reduction
in the number of neuroblasts, which causes aging
with a combination of inflammatory factors [31].
During normal aging, due to the decline in the
metabolic function of neurons and astrocytes,
accumulation of abnormal proteins and DNA
breakage, lipids and other macromolecular
substances are gradually oxidized and cannot
be degraded by the lysosomes. In addition, the
destruction of proteins during aging increases
and affects the phagocytosis of cells, which
leads to the accumulation of denatured proteins
in lysosomes [35, 36]. Several studies have shown
that LBPs can promote the neural differentiation
of neural stem cells and inhibit the abnormal
differentiation of glial cells, thereby improving
brain function during aging and in neurodegenerative diseases, such as AD and macular
degeneration. This neuroprotection of LBPs has
good potential in clinical application [37, 38].
The retina is highly sensitive to chronic oxidative
stress. Due to the mitochondrial metabolism
of retinal pigment epithelial cells and lightsensitive cells, ROS, such as oxygen free radicals,
are generated, which eventually leads to the
degeneration of light-sensitive cells and apoptosis
of retinal neural cells. Through the antioxidative
effect of their active ingredients, LBPs play
important roles in neuroprotection by removing
superoxide anions and free hydroxyl groups;
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increasing the activities of antioxidative enzymes,
superoxidase, and glutathione oxidase; and
promoting the neural differentiation of retinal
neural stem cells [18, 39].
Diabetic retinopathy is mainly caused by
dysfunction of the Rho/ROCK signaling pathway.
Studies in diabetic rats revealed that after LBP
treatment, levels of blood sugar and lipids
significantly reduced, body weight significantly
increased, and the retina thickened [40]. Further
studies revealed that LBPs play these roles by
potentiating signaling pathways involving ROCK
and P-MLC [41]. Using LBPs to treat a rat model
with optic nerve transverse defect, revealed that
LBPs delayed the degeneration of optic nerve stem
cells (RGCs), increased the activity of microglia,
and improved the autophagy effect of optic nerve
stem cells [29].
Through the rat model of nerve injury, it
was found that LBPs can reduce the toxic effects
of scopolamine on the central nervous system,
increase the regeneration of neural stem cells,
and improve the memory and cognitive ability of
rats. LBPs can promote the neural differentiation
of neural stem cells to generate more neurons
[42, 43]. In addition, in rats, LBPs can prevent
hippocampal-dependent spatial memory loss
caused by hypoxia, promote the regeneration of
hippocampal neurons, and decrease the apoptosis
of neurons and astrocytes. Several animal studies
have revealed that LBPs can improve memory
and cognitive abilities in transgenic APP/PS1 mice.
LBP1 was reported to enhance neurogenesis and
restore synaptic dysfunction in the hippocampus
CA3-CA1 pathway [44, 45]. In addition to
improving the neural regeneration of the central
nervous system, LBP was incorporated into the
nanofibrous scaffolds via coaxial electrospinning
and was also showed to promote the proliferation
and neural differentiation of both PC12 cells
and Schwann cells cultured on the scaffolds.
Furthermore, the myelination of Schwann cells
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and neurite outgrowth of dorsal root ganglion
(DRG) sensory neurons were increased on LBP
loaded scaffolds. This study indicated that LBP
can be used as a drug encapsulated into
electrospun nanofibers as tissue engineered
scaffold for peripheral nerve regeneration [46].
Studies have found that LBPs mainly inhibit
protein aggregation and promote autophagy in
glial cells, improve nerve cell activity and nerve
regeneration, and exert inhibitory effects on nerve
degeneration and antiaging [25, 29]. Single-cell
protemics can provide new research ideas for
revealing its molecular mechanism and the
antineural degeneration and aging mechanism
of TCM ingredients.

5

Conclusions and prospect

As a traditional Chinese herbal medicine, L.
barbarum is widely used to treat many diseases.
As one of the main components of L. barbarum,
LBPs have been shown to have antioxidation,
antiaging, and neuroprotective effects in in vitro
and in vivo animal studies. LBPs also have other
biological activities, such as antitumor, immunomodulation, enhancing cell activity, and reducing
tissue damage, caused by toxic substances, such
as CCl4, which induces fibrosis. Using the rabbit
model with diabetes, LBPs were found to inhibit
the expression of NF-κB and Ang II signaling
genes, and played an important protective role
in renal dysfunction caused by diabetes [46].
Recent studies have found that LBPs can
improve the functions of vascular endothelial
cells caused by oxidative stress by inhibiting the
expression of apoptosis-related proteins, thereby
having a protective effect on cardiovascular and
cerebrovascular diseases [16]. In recent years,
researchers from outside China, e.g. America
and some European countries, have also begun
to explore the biological activities of LBPs.
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With the continuous improvement in extraction
methods and functional studies of LBPs, clinical
application of active ingredients and biological
functions of LBPs will increase.
Recent progress in proteomics, metabolomics,
and genomics and other new technologies have
been used to study the different activities of
LBPs. Future research work should focus on the
new biological functions and relationship between
structure and biological activity of LBPs to
promote the development and clinical application
of LBPs. Because of aging and neurodegenerative
diseases, a large number of lysosomal proteins,
abnormal endophagosomes, and denatured
protein aggregates appear in neural cells of the
brain, leading to degeneration and apoptosis of
neural cells. Studies have shown that LBPs can
increase the activity of neural cells and the ability
of neural regeneration by inhibiting protein
aggregation and strengthening the autophagy
of glial cells. For understanding the mechanism
of LBPs on antiaging and neurodegenerative
diseases, it is necessary to use integrated
transcriptomics, metabolomics, and optogenetic
technology to uncover the expression of the key
genes responsible for aging and degeneration.
Therefore, the development and utilization of
LBPs and other active ingredients used in TCM,
and comprehensive studies on the molecular
mechanisms on neuroprotection will be a hot
research topic, with important applications in
the future.

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

Conflict of interests
All contributing authors have no conflict of
interests to declare.

[11]

References
[1] Wu HT, He XJ, Hong YK, et al. Chemical characterization of Lycium barbarum polysaccharides and

[12]

its inhibition against liver oxidative injury of high-fat
mice. Int J Biol Macromol 2010, 46(5): 540–543.
Masci A, Carradori S, Casadei MA, et al. Lycium
barbarum polysaccharides: Extraction, purification,
structural characterisation and evidence about
hypoglycaemic and hypolipidaemic effects. A review.
Food Chem 2018, 254: 377–389.
Tian X, Liang T, Liu Y, et al. Extraction, structural
characterization, and biological functions of polysaccharides: A review. Biomolecules 2019, 9(9): 389.
Ni JG, Au M, Kong H, et al. Lycium barbarum
polysaccharides in ageing and its potential use for
prevention and treatment of osteoarthritis: a systematic
review. BMC Complement Med Ther 2021, 21(1):
212.
Zhou S, Rahman A, Li J, et al. Extraction methods
affect the structure of Goji (Lycium barbarum)
polysaccharides. Molecules 2020, 25(4): 936.
Zhang J, Jia SY, Liu Y, et al. Optimization of
enzyme-assisted extraction of the Lycium barbarum
polysaccharides using response surface methodology.
Carbohydr Polym 2011, 86(2): 1089–1092.
Hao W, Wang SF, Zhao J, et al. Effects of extraction
methods on immunology activity and chemical
profiles of Lycium barbarum polysaccharides. J
Pharm Biomed Anal 2020, 185: 113219.
Liu ZG, Dang J, Wang QL, et al. Optimization of
polysaccharides from Lycium ruthenicum fruit using
RSM and its anti-oxidant activity. Int J Biol Macromol
2013, 61: 127–134.
Muatasim R, Ma H, Yang X. Effect of multimode
ultrasound assisted extraction on the yield of crude
polysaccharides from Lycium barbarum (Goji). Food
Sci Technol Campinas 2018, 38(suppl.1): 160–166.
Cheng XL, Wan JY, Li P, et al. Ultrasonic/microwave
assisted extraction and diagnostic ion filtering strategy
by liquid chromatography-quadrupole time-of-flight
mass spectrometry for rapid characterization of
flavonoids in Spatholobus suberectus. J Chromatogr
A 2011, 1218(34): 5774–5786.
Zeng PJ, Li J, Chen YL, et al. The structures and
biological functions of polysaccharides from traditional
Chinese herbs. Prog Mol Biol Transl Sci 2019, 163:
423–444.
Zhao R, Qiu B, Li QW, et al. LBP-4a improves
insulin resistance via translocation and activation of

https://mc03.manuscriptcentral.com/brainsa

| Brain Science Advances

217

Brain Sci. Adv.

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

GLUT4 in OLETF rats. Food Funct 2014, 5(4):
811–820.
Yang K, Lu TT, Zhan LH, et al. Physicochemical
characterization of polysaccharide from the leaf of
Dendrobium officinale and effect on LPS induced
damage in GES-1 cell. Int J Biol Macromol 2020,
149: 320–330.
Li XM, Ma YL, Liu XJ. Effect of the Lycium
barbarum polysaccharides on age-related oxidative
stress in aged mice. J Ethnopharmacol 2007, 111(3):
504–511.
Liu L, Sha XY, Wu YN, et al. Lycium barbarum
polysaccharides protects retinal ganglion cells against
oxidative stress injury. Neural Regen Res 2020, 15(8):
1526–1531.
Xue SJ, Hu XH, Zhu L, et al. Protective functions of
Lycium barbarum polysaccharides in H2O2-injured
vascular endothelial cells through anti-oxidation
and anti-apoptosis effects. Biomed Rep 2019, 11(5):
207–214.
Gong GP, Dang TT, Deng YN, et al. Physicochemical
properties and biological activities of polysaccharides
from Lycium barbarum prepared by fractional
precipitation. Int J Biol Macromol 2018, 109:
611–618.
Chen L, Li W, Qi D, et al. Lycium barbarum
polysaccharide protects against LPS-induced ARDS
by inhibiting apoptosis, oxidative stress, and
inflammation in pulmonary endothelial cells. Free
Radic Res 2018, 52(4): 480–490.
Xue M-Q, Quan H-F, Wang R, et al. Mitigation
of chronic unpredictable stress-induced cognitive
deficits in mice by Lycium barbarum L (Solanaceae)
polysaccharides. Trop J Pharm Res 2017, 16:
1893–1901.
Liang R, Zhao Q, Zhu Q, et al. Lycium barbarum
polysaccharide-based protection to combat H2O2induced oxidative stress via the Nrf2/HO-1 pathway
in ARPE-19 cells. Mol Med Rep 2021, 24(5): 769.
Enwere EK, Lacasse EC, Adam NJ, et al. Role of the
TWEAK-Fn14-cIAP1-NF-κB signaling axis in the
regulation of myogenesis and muscle homeostasis.
Front Immunol 2014, 5: 34.
Chen SW, Dong YS, Xu C, et al. Involvement of a
chromatin modifier in response to mono-(2-ethylhexyl)
phthalate (MEHP)-induced Sertoli cell injury: probably

http://bsa.tsinghuajournals.com

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

an indirect action via the regulation of NFκB/FasL
circuitry. Biochem Biophys Res Commun 2013, 440(4):
749–755.
Wu Q, Liu LT, Wang XY, et al. Lycium barbarum
polysaccharides attenuate kidney injury in septic rats
by regulating Keap1-Nrf2/ARE pathway. Life Sci
2020, 242: 117240.
Yi R, Liu XM, Dong Q. A study of Lycium barbarum
polysaccharides (LBP) extraction technology and its
anti-aging effect. Afr J Tradit Complement Altern
Med 2013, 10(4): 171–174.
Wang XH, Pang L, Zhang YQ, et al. Lycium barbarum
polysaccharide promotes nigrostriatal dopamine function
by modulating PTEN/AKT/mTOR pathway in a
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
murine model of Parkinson’s disease. Neurochem
Res 2018, 43(4): 938–947.
Long HZ, Cheng Y, Zhou ZW, et al. PI3K/AKT
signal pathway: a target of natural products in the
prevention and treatment of Alzheimer's disease and
Parkinson’s disease. Front Pharmacol 2021, 12:
648636.
Hu J, Yang J, Zhang KY, et al. Protective effect
of LBP on injured optic nerve in rats (in Chinese).
J Ningxia Med Univ 2017, 39(1): 30–33, 117.
Lakshmanan Y, Wong FSY, Yu WY, et al. Lycium
barbarum polysaccharides rescue neurodegeneration
in an acute ocular hypertension rat model under preand posttreatment conditions. Invest Ophthalmol Vis
Sci 2019, 60(6): 2023–2033.
Li HY, Huang M, Luo QY, et al. Lycium barbarum
(wolfberry) increases retinal ganglion cell survival
and affects both microglia/macrophage polarization
and autophagy after rat partial optic nerve transection.
Cell Transplant 2019, 28(5): 607–618.
Schüler T, Mesic I, Madry C, et al. Formation of
NR1/NR2 and NR1/NR3 heterodimers constitutes the
initial step in N-methyl-D-aspartate receptor assembly.
J Biol Chem 2008, 283(1): 37–46.
Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke:
identifying novel targets for neuroprotection. Prog
Neurobiol 2014, 115: 157–188.
Gladding CM, Raymond LA. Mechanisms underlying
NMDA receptor synaptic/extrasynaptic distribution
and function. Mol Cell Neurosci 2011, 48(4):
308–320.

journals.sagepub.com/home/BSA

218

Brain Sci. Adv.

[33] Shi Z, Zhu L, Li T, et al. Neuroprotective mechanisms
of polysaccharides against ischemic insults by
regulating NR2B and NR2A containing NMDA
receptor signaling pathways. Front Cell Neurosci
2017, 11: 288.
[34] Song YJ, Zhao XF, Wang D, et al. Inhibition of LPSinduced brain injury by NR2B antagonists through
reducing assembly of NR2B-CaMKII-PSD95 signal
module. Immunopharmacol Immunotoxicol 2019,
41(1): 86–94.
[35] Vonk WIM, Rainbolt TK, Dolan PT, et al.
Differentiation drives widespread rewiring of the
neural stem cell chaperone network. Mol Cell 2020,
78(2): 329–345.e9.
[36] Fritze J, Ginisty A, McDonald R, et al. Loss of Cxcr5
alters neuroblast proliferation and migration in the
aged brain. Stem Cells 2020, 38(9): 1175–1187.
[37] Tian J-Y, Chen W-W, Cui J, et al. Effect of
polysaccharides on methylmercury-induced abnormal
differentiation of hippocampal stem cells. Exp Ther
Med 2016, 12(2): 683–689.
[38] Mi XS, Feng Q, Lo ACY, et al. Lycium barbarum
polysaccharides related RAGE and Aβ levels in the
Retina of mice with acute ocular hypertension and
promote maintenance of blood retinal barrier. Neural
Regen Res 2020, 15(12): 2344–2352.
[39] Neelam K, Dey S, Sim R, et al. Fructus lycii: a
natural dietary supplement for amelioration of retinal
diseases. Nutrients 2021, 13(1): 246.

[40] Liu K, Yang YC, Zhou F, et al. Inhibition of PI3K/
AKT/mTOR signaling pathway promotes autophagy
and relieves hyperalgesia in diabetic rats. Neuroreport
2020, 31(9): 644–649.
[41] Wang JH, Yao Y, Liu XZ, et al. Protective effects of
Lycium barbarum polysaccharides on blood-retinal
barrier via ROCK1 pathway in diabetic rats. Am J
Transl Res 2019, 11(10): 6304–6315.
[42] Chen WW, Cheng X, Chen JZ, et al. Lycium barbarum
polysaccharides prevent memory and neurogenesis
impairments in scopolamine-treated rats. PLoS One
2014, 9(2): e88076.
[43] Zhao P, Zhou R, Zhu XY, et al. Neuroprotective
effects of Lycium barbarum polysaccharide on focal
cerebral ischemic injury in mice. Neurochem Res
2017, 42(10): 2798–2813.
[44] Zhou Y, Duan YH, Huang SC, et al. Polysaccharides
from Lycium barbarum ameliorate amyloid pathology
and cognitive functions in APP/PS1 transgenic mice.
Int J Biol Macromol 2020, 144: 1004–1012.
[45] Cao SM, Du JL, Hei QH. Lycium barbarum
polysaccharide protects against neurotoxicity via
the Nrf2-HO-1 pathway. Exp Ther Med 2017, 14(5):
4919–4927.
[46] Wang J, Tian LL, He LM, et al. Lycium barbarum
polysaccharide encapsulated Poly lactic-co-glycolic
acid Nanofibers: cost effective herbal medicine for
potential application in peripheral nerve tissue
engineering. Sci Rep 2018, 8(1): 8669.

Mei Mo received her M.S. degree from the college of Biological Sciences and
Technology in Beijing Forestry University in July 2016. Now she is a research associate
in the Experimental Centre, Shandong University of Traditional Chinese Medicine.
Her research focuses on molecular and cellular biological functions of the Chinese
herbs. E-mail: mm000523@126.com

Chuanfei Wei received his Master’s degree from the Department of Physiology,
School of Basic Medical Sciences, Shandong University in July 2015. Now he is a
research associate at the Centre for Stem Cells and Regenerative Medicine, Shandong
University Affiliated Liaocheng People’s Hospital. His research focuses on using
animal models to study the mechanism of stem cell transplantation in the treatment
of neurological diseases such as Alzheimer’s disease and Parkinson’s disease.
E-mail: chuanfei714@163.com
https://mc03.manuscriptcentral.com/brainsa

| Brain Science Advances

Brain Sci. Adv.

219

Fabin Han is a professor and the director of the Laboratory for Stem Cell and
Translational Research, Shandong University of Traditional Chinese Medicine. He
received his M.D. and M.P.H. from School of Medicine, Shandong University, China.
He got his Ph.D. in human molecular genetics through University of Ottawa,
Canada. He has been working on generation and neural differentiation of the
induced pluripotent stem cells for more than 20 years in USA and Canada. His
research has been funded through National Natural Science Foundation of China. He has published
more than 100 peer-reviewed papers in journals including Stem Cells, Cytotherapy, Neurology,
Movement Disorders, and Frontier in Aging Neuroscience. E-mail: fhan2013@126.com

http://bsa.tsinghuajournals.com

journals.sagepub.com/home/BSA

